Analytical Data
-
基因名
CCDC102A
- Application
-
别名
CCDC102A; Coiled-coil domain-containing Protein 102A
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96A19
-
表达区间
1-550aa
-
氨基酸序列
MSHGPSPRLAESPQLSKGSLLTILGSPSPERMGPADSLPPTPPSGTPSPGPPPALPLPPAPALLADGDWESREELRLRELEEARARAAQMEKTMRWWSDCTANWREKWSKVRAERNRAREEVRQLRQRLDALTKELAGARRERQEAQGECEARGRELARLRGARGVADQTRDGPEPEAEREPVRDVGSERPPGSQELELVESLLKSMPEESEDCWEARSLGAGGPRGSSGRQERSRLPWEDTAATEEEASKLTALRLRLDESQKVLLKEREDKLALSRNIEKLEGELSQWKIKYEELSKTKQEMLKQLSILKEAHQDELGRMSEDLEDELGARSSMDRKMAELRGEMERLQAENAAEWGRRERLETEKLGLERENKKLRAQVGDLEEALARRRRQTASALDCDLRASQAALFEKNKELADLKHVHGKLKKQFQEKVAELAHANRRVEQHEAEVKKLRLRVEELKKELAQAEDELDEAHNQARKLQRSLDEQTEQSENLQVQLEHLQSRLRRQQQNAPLFGKIRSARFGTEEAEDGTSDLDEDEDLQIQVA
-
分子量
86.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CCDC102A, a member of the coiled-coil domain-containing protein family, has garnered attention due to its potential involvement in various biological processes, including cellular structure maintenance and signaling pathways. Research indicates that mutations or dysregulation of CCDC102A may be linked to certain human diseases, particularly those affecting the nervous system. This has prompted investigations into its role in cellular metabolism and development, as well as its interactions with other proteins. The increasing prevalence of genetic studies and advancements in protein engineering techniques have facilitated a deeper understanding of CCDC102A's functionality. Recombining CCDC102A into recombinant proteins offers a powerful tool for elucidating its structural and functional properties, enabling researchers to explore its mechanism of action at the molecular level. Through these studies, scientists aim to uncover its potential as a therapeutic target and to elucidate its contributions to cellular homeostasis. Understanding CCDC102A's role and functionality could illuminate new pathways for intervention in diseases where its dysregulation plays a critical role, making it a compelling subject for ongoing research in molecular biology and medicine.












